AbbVie ABBV Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from AbbVie’s reported figures.
Based on trailing twelve months.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's return on assets?
- AbbVie (ABBV) reported return on assets of 2.7% in Q1 2026.
- How has AbbVie's return on assets changed year-over-year?
- AbbVie's return on assets decreased by 9.4% year-over-year, from 2.9% to 2.7%.
- What is the long-term trend for AbbVie's return on assets?
- Over 5 years (2020 to 2025), AbbVie's return on assets has grown at a -4.0% compound annual growth rate (CAGR), from 3.9% to 3.1%.
- What does return on assets mean?
- How much profit the company squeezes out of everything it owns.
- How do you interpret return on assets?
- Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
- How does return on assets compare across companies?
- Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.